Satellite Symposium at the American Heart Association Meeting 2013 Sunday, Nov. 17, 2013 Robert A. Kloner, MD, PhD Professor of Medicine Keck School of.

Slides:



Advertisements
Similar presentations
Protection Devices in PCI-Treatment of Myocardial Infarction for Salvage of Endangered Myocardium Study Presented at American College of Cardiology Scientific.
Advertisements

Presented by: Fahim H. Jafary, M.D., F.A.C.C. Associate Professor of Medicine Aga Khan University Hospital, Karachi March 14, 2008 Primary Percutaneous.
Unstable Angina: Embolism Can Occur Prior to PCI Thrombus in proximal RCA Stain of muscle before injection begins: TIMI Myocardial perfusion grade 1 CM.
Post-conditioning the human heart to reduce infarct size
Postconditioning: A new link in nature’s armor against myocardial ischemia/reperfusion injury Gao Qin
Cardiology Morning Report: Revascularization in Stable Ischemic Heart Disease Bobby Mathew, MD LSU Internal Medicine, HO-II.
Cyclosporine A reduces infarct size and has no detrimental effect of LV remodeling in STEMI patients Michel Ovize Cardiology Hospital and Inserm U886 Lyon.
A Risk Score for Predicting Coronary Artery Bypass Surgery in Patients with Non-ST Elevation Acute Coronary Syndromes Sai Sadanandan, MD*; Christopher.
A few basics of cardiac surgery…. Brett Sheridan, MD Assistant Professor Department of Surgery.
Can we prevent myocardial and renal revascularization injury? Preventive effect of trimetazidine MR on myocardial and renal injury in diabetic patients.
Ischemic Heart Diseases IHD
Intracoronary Serotonin and Endothelin Release After PCI / Stenting Taylor AJ. Am Heart J Aug;148(2): e10 Leosco et al, AJC 1999;84:
1 Dr. Zahoor Ali Shaikh. 2 CORONARY ARTERY DISEASE (CAD)  CAD is most common form of heart disease and causes premature death.  In UK, 1 in 3 men and.
University Medical Center Groningen Thrombus aspiration during primary PCI FZ Thrombus Aspiration during Percutaneous coronary intervention in Acute.
Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. Chapter 53 Management of ST-Elevation Myocardial Infarction.
Acute Coronary Syndromes
ACUTE CORONARY SYNDROME (ACS). ACS Pathophysiology is that of a ruptured or eroded atheromatous plaque. Pathophysiology is that of a ruptured or eroded.
Around-the-Clock Primary Angioplasty: A Process of Care Analysis Comparing Off-Hours and Normal Hours Treatment of Acute STEMI R Leung, D Lundberg, D Galbraith,
1 DIAGNOSTICS OF Acute Coronary Syndromes At the end of this self study the participant will: Verbalize meanings of specific ECG changes: –ST Elevation.
Enhancement of thrombolysis in AMI is an unmet clinical need Increase the rate of reperfusion without increasing bleeding Reduce the time to complete reperfusion.
Myocardial preconditioning Joel Starkopf Departement of Anaesthesiology and Intensive Care University of Tartu Estonia.
Differential regulation of calcium regulatory proteins between sevoflurane postconditioning and delayed remote ischemic preconditioning in an isolated.
RITA-3 Is this a benign lesion in a benign condition? Who Needs Angioplasty in 2008? Stable Angina Stable Angina Keith A A Fox Professor of Cardiology.
Remote Ischemic Conditioning: An Update on Mechanisms Remote Ischemic Conditioning: An Update on Mechanisms Karin Przyklenk PhD Director, Cardiovascular.
Minimise the damage – Pre- and Post-conditioning Dr Derek J Hausenloy The Hatter Cardiovascular Institute, University College London, UK. Myocardial Recovery.
TRI vs TFI in STEMI Shenyang Northern Hospital Wang Shouli Han Yalin.
ANGINA PECTORIS Tb Tuberculosis Carl Matol, RN. ANGINA-to choke CLASSIC/STABLE ANGINA Due to insufficiency of O2 supply against myocardial demand Accumulated.
Angiographic Estimates of Myocardium at Risk During Acute Myocardial Infarction: a Validation Study Using Cardiac MRI José T. Ortiz, Sheridan N. Meyers,
Which Early ST-Elevation Myocardial Infarction Therapy (WEST) Trial Paul W. Armstrong, WEST Steering Committee Published in The European Heart Journal.
Improving outcome of STEMI PCI: Preliminary Results of Crystal AMI trial Rajesh M. Dave, MD Principal investigator on behalf of Crystal AMI Investigators.
S Reducion of infarction size as a target Mohamed Mahmoud Abd El Ghany Mohamed Mahmoud Abd El Ghany Cardiology Professor of Cairo University.
Beyond TIMI 3 Flow CTFC < 14 CTFC > % (n=41) (n = 18/640) (n =35/563) 2.8% p= “TIMI 4” Flow TIMI 3 Flow 14 < CTFC < % % Risk of In Hospital.
Can we protect patients undergoing percutaneous coronary intervention better? Beneficial effects of short- and long-term trimetazidine MR therapy in patients.
UNIVERSITÄT LEIPZIG H E R Z Z E N T R U M Infarct transmurality and infarct size assessed by delayed enhancement magnetic resonance imaging: Association.
Biochemical Investigations In Heart Disaeses
* This Webinar is not part of Unofficial Satellite Events of AHA 2015.
Ischaemic Heart Disease CASE A. CASE A: Mr HA, aged 60 years, was brought in to A&E complaining of chest pain, nausea and a suspected AMI.
Update on Remote Ischemic Conditioning: Basic and Translational Perspectives Update on Remote Ischemic Conditioning: Basic and Translational Perspectives.
Ischemic Conditioning and Endothelial Function Todd Anderson Libin Cardiovascular Institute University of Calgary.
Dr. Sohail Bashir Sulehria
AB 1/03 Non-Coronary Intervention Circulatory Support Advanced Angioplasty 2003 Andreas Baumbach Bristol Royal Infirmary.
A Prospective, Randomized Evaluation of Supersaturated Oxygen Therapy After Percutaneous Coronary Intervention in Acute Anterior Myocardial Infarction.
Biochemical Markers of Myocardial Infarction
Is the Decision-Making after Failure of CTO Angioplasty Same? Infarct Related CTO or Non- Infarct Related CTO (Continue the Procedure in Other Vessel or.
Can we better protect patients who undergo revascularization? Beneficial effects of short- and long-term trimetazidine MR therapy in patients undergoing.
PROTECT: What Have We Learned Lesson 2: TMPG is associated with clinical and biomarker outcomes following PCI.
Myocardial Infarction (MI) Prepared by Miss Fatima Hirzallah RNS, MSN,CNS.
Date of download: 6/1/2016 Copyright © The American College of Cardiology. All rights reserved. From: Early and long-term clinical outcomes associated.
Randomized Early versus Late AbciXimab in Acute Myocardial Infarction treated with primary coronary intervention (RELAx-AMI Trial) Mauro Maioli M.D., Francesco.
Date of download: 7/11/2016 Copyright © The American College of Cardiology. All rights reserved. From: Small molecule glycoprotein IIb/IIIa receptor inhibitors.
Date of download: 9/17/2016 Copyright © The American College of Cardiology. All rights reserved. From: Pharmacologic plaque passivation for the reduction.
Is the Debate Over? Routine Thrombus Aspiration in STEMI (From TAPAS to INFUSE-AMI to TASTE to TOTAL) Stefan James Professor of Cardiology Uppsala Clinical.
CRT 2015 Unmet Needs in STEMI Interventions
Subgroup analyses for mortality after treatment with coronary artery bypass graft (CABG) or percutaneous coronary intervention (PCI). LAD, left anterior.
Biochemical Investigations In Heart Disaeses
Improving Outcomes in Cardiogenic Shock
CORONARY ARTERY DISEASE
Management of ST-Elevation Myocardial Infarction
No Reflow Reflow P value Arrhythmia 40% 18% Lecture Notes
Chapter 28 Management of Patients With Coronary Vascular Disorders
A Webinar Presentation on December 8th, PM PST
STEMI-INITIAL PRESENTATION TIMING 2013 ACC/AHA GUIDELINES
Figure 2 Signalling pathways of ischaemic conditioning
Time Is Myocardium and the Wavefront of Necrosis
American College of Cardiology Presented by Dr. Michel R. Le May
Hypothermia in awake STEMI patients:
A model of variation and accelerating factors in the process of acute care chain of patients with STEMI going for primary PCI. PCI, percutaneous coronary.
CIRCUS Trial design: Patients with anterior STEMI were randomized to IV cyclosporine 2.5 mg/kg (n = 475) vs. placebo (n = 495) immediately before coronary.
Cardiovascular Epidemiology and Epidemiological Modelling
Presentation transcript:

Satellite Symposium at the American Heart Association Meeting 2013 Sunday, Nov. 17, 2013 Robert A. Kloner, MD, PhD Professor of Medicine Keck School of Medicine at USC Director of Research Heart Institute Good Samaritan Hospital Los Angeles, CA Disclosure: Dr. Kloner is a consultant to IC Therapeutics, Speaker and consultant to Gilead, and Consultant and receives grant support from Stealth Peptides, Inc. and Boehringer Iingelheim. Introduction to the Concepts of Ischemic Conditioning

The Preconditioning Phenomenon The heart’s own self-preserving mechanism Brief periods of ischemia (2-5 minutes) prior to a longer duration of ischemia:  Reduce infarct size in most models  Reduce ventricular arrhythmias If we can learn the mechanism of preconditioning, it may lead to potentially important therapies.

Effects of preconditioning on myocardial infarct size in dogs Murry CE, Jennings RB, Reimer KA. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation Nov;74(5):

Clinical Evidence For Preconditioning Less chest pain, ST-segment elevation, lactate production with subsequent compared to first angioplasty balloon inflation Reduction in infarct size, mortality and CHF in patients with history of angina before acute MI Acute tolerance to angina (warm up phenomenon) Studies performed on human cardiac tissue: – ATP levels during CABG – In vitro studies on isolated human muscle – In vitro studies on human myocytes

Kloner RA, Shook T, Przyklenk K, Davis VG, Junio L, Matthews RV, Burstein S, Gibson M, Poole WK, Cannon CP, McCabe C, Braunwald E, for the TIMI 4 Investigators. Previous angina alters in-hospital outcome in TIMI 4. A clinical correlate to preconditioning? Circulation 1995; 91:37-45.

Kloner RA, Shook T, Przyklenk K, Davis VG, Junio L, Matthews RV, Burstein S, Gibson M, Poole WK, Cannon CP, McCabe C, Braunwald E, for the TIMI 4 Investigators. Previous angina alters in-hospital outcome in TIMI 4. A clinical correlate to preconditioning? Circulation 1995; 91:37-45.

Postconditioning Postconditioning is the phenomenon whereby several brief coronary artery reperfusion/reocclusion cycles at the end of a long coronary artery occlusion (stuttering reperfusion) reduces infarct size Zhao, Z-Q et al. Am J Physiol 2003;285:1574 Yang, X-M et al. JACC 2004;44:1103

Vinten-Johansen J, Zhao ZQ, Zatta AJ, Kin H, Halkos ME, Kerendi F. Postconditioning--A new link in nature's armor against myocardial ischemia-reperfusion injury. Basic Res Cardiol Jul;100(4):

Vinten-Johansen J, Zhao ZQ, Zatta AJ, Kin H, Halkos ME, Kerendi F. Postconditioning--A new link in nature's armor against myocardial ischemia-reperfusion injury. Basic Res Cardiol Jul;100(4):

Kloner RA, Dow J, Bhandari A. Postconditioning markedly attenuates ventricular arrhythmias after ischemia-reperfusion. J Cardiovasc Pharmacol Ther Mar;11(1):55-63.

Ventricular Arrhythmias with and without postconditioning Kloner RA, Dow J, Bhandari A. Postconditioning markedly attenuates ventricular arrhythmias after ischemia- reperfusion. J Cardiovasc Pharmacol Ther Mar;11(1):55-63.

Experimental protocol Staat P, Rioufol G, Piot C, Cottin Y, Cung TT, L'Huillier I, Aupetit JF, Bonnefoy E, Finet G, André-Fouët X, Ovize M. Postconditioning the human heart. Circulation Oct 4;112(14):

Serum CK release over the first 72 hours of reperfusion

Copyright ©2005 American Heart Association Blush grade and ST-segment shift during reperfusion Staat P, Rioufol G, Piot C, Cottin Y, Cung TT, L'Huillier I, Aupetit JF, Bonnefoy E, Finet G, André-Fouët X, Ovize M. Postconditioning the human heart. Circulation Oct 4;112(14):

Potential Mechanisms of Postconditioning A.Triggers including: 1.Adenosine 2.Opioids 3.Erythropoietin 4.Endogenous nitric oxide 5.Reactive oxygen species 6.Acetylcholine 7.Tissue factors 8.Pro-inflammatory cytokines and bradykinin 9.Hydrogen sulfide B.Mediators –Reperfusion injury salvage kinase pathways including: 1.Phosphoinositide-3-kinase 2.Extra-cellular signal regulated kinase (1/2) pathways 3.Protein kinases G and C C.End-effectors such as: 1.Mitochondrial permeability transition pore 2.Mitochondrial potassium ATP channel Kaur S, Singh N. Molecular aspects of ischaemic postconditioning. Fundamental & Clinical Pharmacology 2009;23:

Piot C, Croisille P, Staat P, Thibault H, Rioufol G, Mewton N, Elbelghiti R, Cung TT, Bonnefoy E, Angoulvant D, Macia C, Raczka F, Sportouch C, Gahide G, Finet G, André-Fouët X, Revel D, Kirkorian G, Monassier JP, Derumeaux G, Ovize M. Effect of cyclosporine on reperfusion injury in acute myocardial infarction. N Engl J Med Jul 31;359(5):

Concordant improvements in coronary flow reserve and ST-segment resolution during percutaneous coronary intervention for acute myocardial infarction: a benefit of postconditioning 24 patients with evolving anterior STEMI were randomized to ischemic postconditioning or usual care during PCI Postconditioned pts had a greater and more rapid resolution of ST segment elevation (70% vs. 48%, p = ) by the end of the procedure Postconditioned pts had greater hyperemic coronary vasodilator reserve (2.2 vs. 1.5, p< 0.001) Peak serum creatine kinase was lower in postconditioned pts (1,524 vs. 1,862 IU/L in controls, p = 0.03) Conclusion: Postconditioning performed during PCI for STEMI improved ST-segment resolution and coronary flow reserve, measures of microcirculatory function, as well as reducing tissue necrosis. Laskey WK, Yoon S, Calzada N, Ricciardi MJ. Concordant improvements in coronary flow reserve and ST-segment resolution during percutaneous coronary intervention for acute myocardial infarction: a benefit of postconditioning. Catheter Cardiovasc Interv Aug 1;72(2):212-20

Remote Ischemic Preconditioning or Ischemic Conditioning at a Distance Ischemic conditioning of one vascular bed may protect a remote vascular bed. This could occur within the same organ or between different organs.

Regional ischemic preconditioning protects remote virgin myocardium from subsequent sustained coronary occlusion Przyklenk K, Bauer B, Ovize M, Kloner RA, Whittaker P. Regional ischemic 'preconditioning' protects remote virgin myocardium from subsequent sustained coronary occlusion. Circulation Mar;87(3):893-9 Showed that “Brief episodes of ischemia in one vascular bed protect remote, virgin myocardium from subsequent sustained coronary artery occlusion in canine model.”

Regional ischemic preconditioning protects remote virgin myocardium Przyklenk K. et al. Circulation 1993;87:893

Ischemic preconditioning at a distance. Reduction of myocardial infarct size by partial reduction of blood supply combined with rapid stimulation of the gastrocnemius muscle in rabbit. Birnbaum Y, Hale SL, Kloner RA. Ischemic preconditioning at a distance: reduction of myocardial infarct size by partial reduction of blood supply combined with rapid stimulation of the gastrocnemius muscle in the rabbit. Circulation Sep 2;96(5): Showed that remote ischemia of a skeletal muscle could precondition the myocardium.

Remote ischaemic conditioning before hospital admission, as a complement to angioplasty, and effect on myocardial salvage in patients with acute myocardial infarction: a randomised trial 333 patients with first AMI randomized to primary PCI with or without remote conditioning (4 cycles of 5-minute brachial artery cuff inflation & 5 minutes deflation) Median salvage index by myocardial perfusion imaging 0.75 in remote conditioning group versus 0.55 in control group, p = 0.03 Conclusion: Remote ischemic conditioning before hospital admission increases myocardial salvage and is safe. Bøtker HE, Kharbanda R, Schmidt MR, Bøttcher M, Kaltoft AK, Terkelsen CJ, Munk K, Andersen NH, Hansen TM, Trautner S, Lassen JF, Christiansen EH, Krusell LR, Kristensen SD, Thuesen L, Nielsen SS, Rehling M, Sørensen HT, Redington AN, Nielsen TT. Remote ischaemic conditioning before hospital admission, as a complement to angioplasty, and effect on myocardial salvage in patients with acute myocardial infarction: a randomised trial. Lancet Feb 27;375(9716):727.

Ischemic Conditioning Reducing myocardial infarct size Reducing cardiac damage during percutaneous coronary intervention Protecting the myocardium during coronary artery bypass grafting and other procedures requiring cardiopulmonary bypass Protecting the vasculature during vascular surgery procedures Unstable angina Before activities that reproducibly cause angina in patients with stable angina Protecting donor hearts before excision and transport Protecting other organs (brain, kidney) during episodes of ischemia